The Acentus transaction follows Henry Schein’s acquisition of Prism Medical Products, LLC in 2021 and Shield Healthcare and ...

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...

Henry Schein HSIC is well positioned to gain from its extensive global foothold and diverse channel mix. Yet, global economic ...

This was the stock's second consecutive day of losses.

Shares of Henry Schein, Inc. (NASDAQ:HSIC – Get Free Report) have been assigned an average recommendation of “Moderate Buy” ...

Valued at a market cap of $8.8 billion, Henry Schein, Inc. (HSIC) provides healthcare products and services to dental ...

NAW said Henry Schein’s CEO won the award for his leadership, service and engagement with the association and distribution ...

The projected fair value for Henry Schein is US$67.04 based on 2 Stage Free Cash Flow to Equity With US$70.70 share price, Henry Schein appears to be trading close to its estimated fair value ...

Henry Schein has opened the Henry Schein Cares Foundation 2025 Relief Fund to support those impacted by the Los Angeles area wildfires.

Dental and medical professionals who may experience operational, logistical, or financial issues are encouraged to call 800-999-9729 ...

Henry Schein, Inc.’s HSIC joint venture, Henry Schein One, is driving strong growth in its core products and introducing new solutions. The company’s robust acquisition strategy helps it to ...

Henry Schein (Nasdaq: HSIC) announced today that it completed the acquisition of substantially all the assets of Acentus.